vs
Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
ACACIA RESEARCH CORP is the larger business by last-quarter revenue ($50.1M vs $37.2M, roughly 1.3× GYRE THERAPEUTICS, INC.). ACACIA RESEARCH CORP runs the higher net margin — 6.8% vs -3.7%, a 10.5% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 2.6%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs 17.0%).
Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
ACTG vs GYRE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.1M | $37.2M |
| Net Profit | $3.4M | $-1.4M |
| Gross Margin | 12.8% | 95.3% |
| Operating Margin | -26.1% | 0.3% |
| Net Margin | 6.8% | -3.7% |
| Revenue YoY | 2.6% | 33.4% |
| Net Profit YoY | 125.5% | -340.1% |
| EPS (diluted) | $0.03 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.1M | $37.2M | ||
| Q3 25 | $59.4M | $30.6M | ||
| Q2 25 | $51.2M | $26.8M | ||
| Q1 25 | $124.4M | $22.1M | ||
| Q4 24 | $48.8M | $27.9M | ||
| Q3 24 | $23.3M | $25.5M | ||
| Q2 24 | $25.8M | $25.2M | ||
| Q1 24 | $24.3M | $27.2M |
| Q4 25 | $3.4M | $-1.4M | ||
| Q3 25 | $-2.7M | $5.9M | ||
| Q2 25 | $-3.3M | $1.6M | ||
| Q1 25 | $24.3M | $3.7M | ||
| Q4 24 | $-13.4M | $569.0K | ||
| Q3 24 | $-14.0M | $2.9M | ||
| Q2 24 | $-8.4M | $4.5M | ||
| Q1 24 | $-186.0K | $9.9M |
| Q4 25 | 12.8% | 95.3% | ||
| Q3 25 | 21.2% | 94.7% | ||
| Q2 25 | 12.8% | 95.7% | ||
| Q1 25 | 47.4% | 95.9% | ||
| Q4 24 | 17.6% | 95.8% | ||
| Q3 24 | 10.1% | 96.2% | ||
| Q2 24 | 26.2% | 96.9% | ||
| Q1 24 | 49.2% | 96.4% |
| Q4 25 | -26.1% | 0.3% | ||
| Q3 25 | -10.8% | 22.7% | ||
| Q2 25 | -24.2% | 8.1% | ||
| Q1 25 | 30.8% | 10.3% | ||
| Q4 24 | -32.4% | 2.4% | ||
| Q3 24 | -44.1% | 16.6% | ||
| Q2 24 | -18.4% | 12.7% | ||
| Q1 24 | -8.6% | 29.7% |
| Q4 25 | 6.8% | -3.7% | ||
| Q3 25 | -4.6% | 19.4% | ||
| Q2 25 | -6.4% | 5.9% | ||
| Q1 25 | 19.5% | 16.9% | ||
| Q4 24 | -27.5% | 2.0% | ||
| Q3 24 | -60.0% | 11.2% | ||
| Q2 24 | -32.7% | 18.0% | ||
| Q1 24 | -0.8% | 36.6% |
| Q4 25 | $0.03 | $-0.01 | ||
| Q3 25 | $-0.03 | $0.03 | ||
| Q2 25 | $-0.03 | $0.00 | ||
| Q1 25 | $0.25 | $0.00 | ||
| Q4 24 | $-0.14 | $0.00 | ||
| Q3 24 | $-0.14 | $0.01 | ||
| Q2 24 | $-0.08 | $0.01 | ||
| Q1 24 | $0.00 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $306.7M | $52.4M |
| Total DebtLower is stronger | $91.9M | — |
| Stockholders' EquityBook value | $543.5M | $106.0M |
| Total Assets | $771.0M | $166.1M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $306.7M | $52.4M | ||
| Q3 25 | $301.8M | $60.0M | ||
| Q2 25 | $316.7M | $54.4M | ||
| Q1 25 | $272.0M | $29.9M | ||
| Q4 24 | $273.9M | $26.7M | ||
| Q3 24 | $410.9M | $25.1M | ||
| Q2 24 | $441.9M | $25.1M | ||
| Q1 24 | $498.4M | $37.4M |
| Q4 25 | $91.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $543.5M | $106.0M | ||
| Q3 25 | $537.6M | $101.9M | ||
| Q2 25 | $538.6M | $92.0M | ||
| Q1 25 | $540.2M | $68.1M | ||
| Q4 24 | $514.8M | $63.3M | ||
| Q3 24 | $540.2M | $63.2M | ||
| Q2 24 | $560.7M | $60.4M | ||
| Q1 24 | $568.3M | $56.6M |
| Q4 25 | $771.0M | $166.1M | ||
| Q3 25 | $768.9M | $159.4M | ||
| Q2 25 | $775.5M | $152.6M | ||
| Q1 25 | $801.6M | $129.8M | ||
| Q4 24 | $756.4M | $125.4M | ||
| Q3 24 | $707.6M | $125.2M | ||
| Q2 24 | $753.6M | $120.9M | ||
| Q1 24 | $631.7M | $122.0M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.2M | $-5.6M |
| Free Cash FlowOCF − Capex | — | $-5.8M |
| FCF MarginFCF / Revenue | — | -15.5% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | 22.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.2M | $-5.6M | ||
| Q3 25 | $9.5M | $4.7M | ||
| Q2 25 | $50.1M | $2.1M | ||
| Q1 25 | $2.4M | $-129.0K | ||
| Q4 24 | $50.1M | $-2.8M | ||
| Q3 24 | $-593.0K | $1.7M | ||
| Q2 24 | $16.1M | $-5.5M | ||
| Q1 24 | $54.8M | $2.9M |
| Q4 25 | — | $-5.8M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | $335.0K | $-251.0K | ||
| Q4 24 | $-98.5M | $-2.8M | ||
| Q3 24 | $-2.8M | $1.0M | ||
| Q2 24 | $-126.7M | $-6.9M | ||
| Q1 24 | $54.6M | $2.7M |
| Q4 25 | — | -15.5% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | 0.3% | -1.1% | ||
| Q4 24 | -201.8% | -10.1% | ||
| Q3 24 | -12.1% | 4.1% | ||
| Q2 24 | -490.5% | -27.5% | ||
| Q1 24 | 224.4% | 9.8% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 2.2% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | 1.7% | 0.6% | ||
| Q4 24 | 304.4% | 0.2% | ||
| Q3 24 | 9.6% | 2.7% | ||
| Q2 24 | 553.0% | 5.8% | ||
| Q1 24 | 1.1% | 0.9% |
| Q4 25 | 22.01× | — | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 1.32× | ||
| Q1 25 | 0.10× | -0.03× | ||
| Q4 24 | — | -4.85× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | -1.21× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACTG
| Energy Operations | $16.0M | 32% |
| Transportation Safety | $10.4M | 21% |
| Office Storage And Display Solutions | $8.4M | 17% |
| Printers Consumables And Parts | $6.5M | 13% |
| Natural Gas Reserves | $5.1M | 10% |
| Natural Gas Liquids Reserves | $3.3M | 7% |
GYRE
Segment breakdown not available.
